1st Quarter - Report

WINNING STRATEGIES WASHINGTON for NOVARTIS

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY11, FY12 Department of Defense Appropriations

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
MICHAEL A MEROLA —
DONNA MULLINS —
ROBERT ZUCKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Patient Protection and Innovative Biologic Medicines Act of 2009 H.R. 1427and H.R. 1548 Affordable Biologics for Consumers Implementation of health care reform

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
MICHAEL A MEROLA —
DONNA MULLINS —
ROBERT ZUCKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (112th), H.R. 1427 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.